BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17349460)

  • 1. Oral beta-lactams in the treatment of acute otitis media.
    Block SL; Doern GV; Pfaller MA
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):19S-30S. PubMed ID: 17349460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
    Dowell SF; Butler JC; Giebink GS; Jacobs MR; Jernigan D; Musher DM; Rakowsky A; Schwartz B
    Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current management of pediatric acute otitis media.
    Leibovitz E; Broides A; Greenberg D; Newman N
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):151-61. PubMed ID: 20109045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
    Ubukata K; Morozumi M; Sakuma M; Adachi Y; Mokuno E; Tajima T; Iwata S;
    J Infect Chemother; 2019 Sep; 25(9):720-726. PubMed ID: 30987951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
    Leibovitz E
    Paediatr Drugs; 2003; 5 Suppl 1():1-12. PubMed ID: 14632101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006.
    Pichichero ME; Casey JR; Hoberman A; Schwartz R
    Clin Pediatr (Phila); 2008 Nov; 47(9):901-6. PubMed ID: 18559884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute otitis media caused by Streptococcus pyogenes in children.
    Segal N; Givon-Lavi N; Leibovitz E; Yagupsky P; Leiberman A; Dagan R
    Clin Infect Dis; 2005 Jul; 41(1):35-41. PubMed ID: 15937760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complicated otitis media and its implications.
    Leibovitz E
    Vaccine; 2008 Dec; 26 Suppl 7():G16-9. PubMed ID: 19094932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.
    Revai K; McCormick DP; Patel J; Grady JJ; Saeed K; Chonmaitree T
    Pediatrics; 2006 May; 117(5):1823-9. PubMed ID: 16651345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.
    Block SL
    Pediatr Infect Dis J; 1997 Apr; 16(4):449-56. PubMed ID: 9109158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology of otitis media in Costa Rican children, 1999 through 2001.
    Arguedas A; Dagan R; Soley C; Loaiza C; Knudsen K; Porat N; Pérez A; Brilla E; Herrera ML
    Pediatr Infect Dis J; 2003 Dec; 22(12):1063-8. PubMed ID: 14688566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacodynamic parameters to evaluate antibiotic cover as empirical treatment].
    Aguilar L; Granizo JJ
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):165-6. PubMed ID: 21334784
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial resistance of Haemophilus influenzae isolated from the nasopharynx of Japanese children with acute otitis media.
    Hotomi M; Fujihara K; Sakai A; Billal DS; Shimada J; Suzumoto M; Yamanaka N
    Acta Otolaryngol; 2006 Mar; 126(3):240-7. PubMed ID: 16618648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute otitis media caused by drug-resistant bacteria: correlation with antibiotic treatment.
    Sakakura K; Chikamatsu K; Furukawa M; Shibasaki M; Takegoshi T; Takahashi K; Furuya N
    Acta Otolaryngol; 2004 Nov; 124(9):1008-14. PubMed ID: 15513542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute otitis media: influence of the PCV-7 vaccine on changes in the disease and its management.
    Brunton S; Pichichero ME
    J Fam Pract; 2005 Nov; 54(11):961-8. PubMed ID: 16266602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.